Rare heritable skin diseases: Targets for regenerative medicine

Journal of Investigative Dermatology

Volumn 132, Issue 11, 2012, Pages 2485-2488

  Uitto, Jouni ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; KALININ; PLECTIN; SMALL INTERFERING RNA;

ALLELE; BONE MARROW TRANSPLANTATION; CELL THERAPY; EPIDERMOLYSIS BULLOSA; FIBROBLAST; GENE EXPRESSION; GENE GUN; GENE MUTATION; GENE SILENCING; GENE THERAPY; GENETIC DISORDER; GENETIC IDENTIFICATION; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MISSENSE MUTATION; MOLECULAR GENETICS; MOSAICISM; PLURIPOTENT STEM CELL; PREVALENCE; PRIORITY JOURNAL; PROGERIA; QUALITY OF LIFE; RARE DISEASE; REGENERATIVE MEDICINE; REVIEW; SKIN DISEASE; SKIN FIBROBLAST; SKIN FRAGILITY; UNITED STATES; WOUND HEALING;

EID: 84867760135     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.334     Document Type: Editorial

References (22)

1. Bruckner-Tuderman L, McGrath JA, Robinson EC et al. (2010) Animal models of epidermolysis bullosa: update 2010. J Invest Dermatol 130:1485-8
2. Conget P, Rodriguez F, Kramer S et al. (2010) Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy 12:429-31
3. Higgins CA, Itoh M, Inoue K et al. (2012) Reprogramming of human hair follicle dermal papilla cells into induced pluripotent stem cells. J Invest Dermatol 132:1725-7
4. Gaestel A (2012) A Philadelphia meeting talks treatment for a rare disease. The Philadelphia Inquirer, 15 July 2012: (http://articles.philly.2012- 07-15/news/32675524-1-rare-diseases-mutant-protein-nih)
5. Itoh M, Kiuru M, Cairo MS, Christiano AM (2011) Generation of keratinocytes from normal and recessive dystrophic epidermolysis bullosa-induced pluripotent stem cells. Proc Natl Acad Sci USA 108: 8797-802
6. Kiritsi D, Pigors M, Tantcheva-Poor I et al. (2012) Epidermolysis bullosa simplex Ogna revisited. J Invest Dermatol, in press.
7. Leachman SA, Hickerson RP, Schwartz ME et al. (2010) First-in-human mutation-targeted siRNA phase Ib trial of an inherited skin disorder. Mol Ther 18:442-6
8. Lessard JC, Coulombe PA (2012) Keratin 16-null mice develop palmoplantar keratoderma, a hallmark feature of pachyonychia congenita and related disorders. J Invest Dermatol 132:1384-91
9. Padalon-Brauch G, Ben Amitai D, Vodo D et al. (2012) Digenic inheritance in epidermolysis bullosa simplex. J Invest Dermatol, in press
10. Pasmooij AMG, Nijenhuis M, Brander R et al. (2012) Natural gene therapy may occur in all patients with generalized non-Herlitz junctional epidermolysis bullosa with COL17A1 mutations. J Invest Dermatol 132:1374-1383.
11. Pendaries V, Gasc G, Titeux M et al. (2012) siRNA-mediated allele-specific inhibition of mutant type VII collagen in dominant dystrophic epidermolysis bullosa. J Invest Dermatol 132:1741-3
12. Terry SF, Terry PF, Rauen KA et al. (2007) Advocacy groups as research organizations: the PXE International example. Nat Rev Genet 8:157-64 (Pubitemid 46122844)
13. Tolar J, Xia L, Riddle MJ et al. (2011) Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa. J Invest Dermatol 131:848-56
14. Tolar J, Xia L, Lees C et al. (2012) Keratinocytes from induced pluripotent stem cells in junctional epidermolysis bullosa. J Invest Dermatol, in press.
15. Uitto J (2001) Patient advocacy organizations partner genetic research, and forge the agenda. Trends Mol Med 7:182
16. Uitto J (2009) Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies. Acta Derm Venereol 89:228-35
17. Uitto J, Bercovitch L, Terry SF, Terry PF (2010a) Pseudoxanthoma elasticum: progress in diagnostics and research towards treatment: summary of the 2010 PXE International Research Meeting. Am J Med Genet 155A:1517-26
18. Uitto J, McGrath JA, Rodeck U et al. (2010b) Progress in epidermolysis bullosa research: toward treatment and cure. J Invest Dermatol 130:1778-84
19. Uitto J, Christiano AM, McLean WH et al. (2012) Novel molecular therapies for heritable skin disorders. J Invest Dermatol 132:820-8
20. Wagner JE, Ishida-Yamamoto A, McGrath JA et al. (2010) Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. N Engl J Med 363:629-39
21. Wilson NJ, Perez ML, Vahlquist A et al. (2012) Homozygous dominant missense mutation in keratin 17 leads to alopecia in addition to severe pachyonychia congenita. J Invest Dermatol 132:1921-4
22. Wong T, Gammon L, Liu L et al. (2008) Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J Invest Dermatol 128:2179-89